A detailed history of Brown Brothers Harriman & CO transactions in Pfizer Inc stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 204,695 shares of PFE stock, worth $5.47 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
204,695
Previous 210,606 2.81%
Holding current value
$5.47 Million
Previous $5.84 Million 2.0%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $149,311 - $174,965
-5,911 Reduced 2.81%
204,695 $5.73 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $148,505 - $170,531
5,736 Added 2.8%
210,606 $5.84 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $740,367 - $961,655
-28,334 Reduced 12.15%
204,870 $5.9 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $149,731 - $175,021
4,666 Added 2.04%
233,204 $7.74 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $37,420 - $43,294
-1,036 Reduced 0.45%
228,538 $8.38 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $18,237 - $23,742
463 Added 0.2%
229,574 $9.37 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $1.26 Million - $1.65 Million
-30,250 Reduced 11.66%
229,111 $11.7 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $518,512 - $632,973
-11,849 Reduced 4.37%
259,361 $11.4 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $344,601 - $408,589
7,406 Added 2.81%
271,210 $14.2 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $236,527 - $293,087
-5,170 Reduced 1.92%
263,804 $13.7 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $538,936 - $798,883
13,043 Added 5.1%
268,974 $15.9 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $696,412 - $894,602
-17,743 Reduced 6.48%
255,931 $11 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $164,790 - $186,680
-4,589 Reduced 1.65%
273,674 $10.7 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $2 Million - $2.26 Million
-59,825 Reduced 17.7%
278,263 $10.1 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $321,245 - $408,490
9,598 Added 2.92%
338,088 $12.4 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $57,658 - $67,646
-1,816 Reduced 0.55%
328,490 $12.1 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $255,176 - $309,566
8,472 Added 2.63%
330,306 $10.8 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $791,627 - $1.13 Million
-29,287 Reduced 8.34%
321,834 $10.5 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $236,793 - $268,730
7,193 Added 2.09%
351,121 $13.8 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $1.52 Million - $1.97 Million
46,830 Added 15.76%
343,928 $12.4 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $505,405 - $567,453
13,667 Added 4.82%
297,098 $12.9 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $163,425 - $179,549
-4,358 Reduced 1.51%
283,431 $12 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $45,625 - $52,017
-1,186 Reduced 0.41%
287,789 $12.6 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $8,203 - $9,950
238 Added 0.08%
288,975 $12.7 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $59,363 - $63,287
-1,800 Reduced 0.62%
288,737 $10.5 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $529,291 - $614,050
-16,587 Reduced 5.4%
290,537 $10.3 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $325,415 - $345,277
-9,784 Reduced 3.09%
307,124 $11.1 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $334,211 - $368,171
-10,781 Reduced 3.29%
316,908 $11.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
327,689
327,689 $11 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.